Recent advances and challenges in antibacterial drug development: Editorial
- PMID: 35350116
- PMCID: PMC8957239
- DOI: 10.5599/admet.1315
Recent advances and challenges in antibacterial drug development: Editorial
References
-
- Theuretzbacher U., Gottwalt S., Beyer P., Butler M., Czaplewski L., Lienhardt C., Moja L., Paul M., Paulin S., Rex J.H., Silver L.L., Spigelman M., Thwaites G.E., Paccaud J.-P., Harbarth S.. Analysis of the clinical antibacterial and antituberculosis pipeline. The Lancet Infectious Diseases 2019, 19(2) (2019) e40-e50. https://doi.org/10.1016/S1473-3099(18)30513-9. 10.1016/S1473-3099(18)30513-9 - DOI - PubMed
-
- Projan S. J.. Why is big Pharma getting out of antibacterial drug discovery? Curr. Opin. Microbiol. 6(5) (2003) 427-430. https://doi.org/10.1016/j.mib.2003.08.003\t_blank. 10.1016/j.mib.2003.08.003\t_blank - DOI - PubMed
-
- Theuretzbacher U., Outterson K., Engel A., Karlen A., A. The global preclinical antibacterial pipeline. Nat. Rev. Microbiol. 18(5) (2020) 275-285. https://doi.org/10.1038/s41579-019-0288-0. 10.1038/s41579-019-0288-0 - DOI - PMC - PubMed
-
- Silver L.L.. Challenges of antibacterial discovery. Clin. Microbiol. Rev. 24(1) (2011) 71-109. https://doi.org/10.1128/CMR.00030-10. 10.1128/CMR.00030-10 - DOI - PMC - PubMed
-
- Gigante V., Sati H., Beyer P.. Recent advances and challenges in antibacterial drug development. ADMET and DMPK 10 (2022) 147-151. https://doi.org/10.5599/admet.1271. 10.5599/admet.1271 - DOI - PMC - PubMed
Publication types
LinkOut - more resources
Full Text Sources